Revolutionizing In Vivo Drug Delivery. Watch Tebubio and Certest Pharma Webinar

Download the slides

Access the webinar slides and go deeper into Certest Pharma capabilities for in vivo delivery projects.

Explore an insightful webinar where our partner Certest Pharma showcases the transformative potential of their ionizable lipids and capabilities for in vivo drug delivery.

What is this webinar about?

Despite significant technological advancements, in vivo drug delivery still faces major challenges, including drug stability, precise targeting, and overcoming biological barriers and immune responses.

In this webinar, discover how Certest Pharma's cutting-edge technology has enabled researchers to overcome these challenges for more efficient in vivo delivery. Learn how their advanced lipid technology enhances extrahepatic targeting and active targeting strategies, while their scalable and flexible business model empowers researchers to leverage this innovation for drug development.

Whether you're exploring targeted drug delivery solutions or seeking a strategic partner to advance your in vivo research, this webinar will showcase how Certest Pharma is shaping the future of nucleic acid therapeutics.

Webinar summary

Unveil the latest advancements in in vivo drug delivery with Certest Smart Lipids & Smarter Targeting.

Advanced strategies to enhance in vivo drug delivery.
Certest Pharma’s proprietary lipids for precise and efficient encapsulation of therapeutic payloads.
Certest Pharma’s lipids for Extrahepatic and Active Targeting Strategies.
Flexible and Scalable Business Model to adapt this technology to your needs.

Q&A of the live session

Do you have a list of organ specific targeting lipids?

Yes. The organs available to target with Passive Targeting are: - Liver / Spleen / Lung Certest's Pharma can also perform (on demand) peptide conjugation for active targeting.
Are these lipids for targeted delivery available to order?

Yes these lipids can be ordered in Europe directly on Tebubio web site.
Has they tested their lipids with DNA cargo for in vivo delivery? If so, up to which size?

Yes. The maximum size where Certest has been able to encapsulate DNA-LNPs is around 15-17.000 bp
Has Certest's pharma tried targeted delivery by coating LNPs with specific cell surface receptors?

Yes. Certest employs an active targeting strategy to deliver the encapsulated cargo in its LNPs to specific cells. This conjugation is achieved by attaching peptides to the specific lipid in the LNP. The peptide interacts specifically with a designated receptor.